company background image
BIOT logo

Biotage OM:BIOT Stock Report

Last Price

kr164.70

Market Cap

kr13.2b

7D

0.7%

1Y

34.7%

Updated

25 Apr, 2024

Data

Company Financials +

BIOT Stock Overview

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

BIOT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Biotage AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biotage
Historical stock prices
Current Share Pricekr164.70
52 Week Highkr187.10
52 Week Lowkr83.05
Beta0.80
1 Month Change-10.54%
3 Month Change11.43%
1 Year Change34.67%
3 Year Change-13.32%
5 Year Change31.65%
Change since IPO61.47%

Recent News & Updates

Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Apr 17
Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Apr 08
Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Apr 03
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Recent updates

Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Apr 17
Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Apr 08
Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Apr 03
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Mar 04
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Feb 22
Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Feb 21
Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 18
Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Feb 08
Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

Jan 07
Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Dec 08
At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Oct 27
Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Jul 12
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Jun 08
An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

May 24
Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 05
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Mar 12
These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 21
Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Jan 06
Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Dec 03
Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Oct 27
Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Oct 07
Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Biotage (STO:BIOT) Could Easily Take On More Debt

Sep 03
Biotage (STO:BIOT) Could Easily Take On More Debt

Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

Jul 10
Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jun 25
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

May 28
Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 23
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Mar 29
Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Mar 14
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 28
Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Feb 13
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jan 23
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Is Biotage (STO:BIOT) A Risky Investment?

Dec 10
Is Biotage (STO:BIOT) A Risky Investment?

Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Nov 03
Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Biotage (STO:BIOT) Has A Rock Solid Balance Sheet

Aug 17
Biotage (STO:BIOT) Has A Rock Solid Balance Sheet

Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Jul 24
Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Shareholder Returns

BIOTSE Life SciencesSE Market
7D0.7%-0.3%-0.7%
1Y34.7%0.6%4.4%

Return vs Industry: BIOT exceeded the Swedish Life Sciences industry which returned 7% over the past year.

Return vs Market: BIOT exceeded the Swedish Market which returned 10.3% over the past year.

Price Volatility

Is BIOT's price volatile compared to industry and market?
BIOT volatility
BIOT Average Weekly Movement6.4%
Life Sciences Industry Average Movement6.7%
Market Average Movement6.1%
10% most volatile stocks in SE Market13.1%
10% least volatile stocks in SE Market3.5%

Stable Share Price: BIOT has not had significant price volatility in the past 3 months.

Volatility Over Time: BIOT's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969674Torben Jorgensenwww.biotage.com

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns.

Biotage AB (publ) Fundamentals Summary

How do Biotage's earnings and revenue compare to its market cap?
BIOT fundamental statistics
Market capkr13.18b
Earnings (TTM)kr236.00m
Revenue (TTM)kr1.98b

55.8x

P/E Ratio

6.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOT income statement (TTM)
Revenuekr1.98b
Cost of Revenuekr749.00m
Gross Profitkr1.23b
Other Expenseskr996.00m
Earningskr236.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 16, 2024

Earnings per share (EPS)2.95
Gross Margin62.19%
Net Profit Margin11.91%
Debt/Equity Ratio3.9%

How did BIOT perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

52%

Payout Ratio

Does BIOT pay a reliable dividends?

See BIOT dividend history and benchmarks
When do you need to buy BIOT by to receive an upcoming dividend?
Biotage dividend dates
Ex Dividend DateApr 26 2024
Dividend Pay DateMay 03 2024
Days until Ex dividend1 day
Days until Dividend pay date6 days

Does BIOT pay a reliable dividends?

See BIOT dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.